Canadian Cancer Society logo

Uterine cancer

You are here: 

Survival statistics for uterine cancer

Survival statistics for uterine cancer are very general estimates and must be interpreted very carefully. Because these statistics are based on the experience of groups of people, they cannot be used to predict a particular person’s chances of survival.

There are many different ways to measure and report cancer survival statistics. Your doctor can explain the statistics for uterine cancer and what they mean to you.

Relative survival

Relative survival looks at how likely people with cancer are to survive after their diagnosis compared to people in the general population who do not have cancer, but who share similar characteristics (such as age and sex).

In Canada, a 5-year relative survival statistic is reported for uterine cancer. The 5-year relative survival for uterine cancer is 85%. This means that, on average, women diagnosed with uterine cancer are 85% as likely to live 5 years after their diagnosis as women in the general population.

Observed survival

Observed survival is the percentage of people with a particular cancer who are alive for a specified period of time after their diagnosis and is based on the stage of the cancer at the time of diagnosis. However, observed survival does not consider the cause of death, so people could have died from cancer or from other causes.

Survival by type of tumour and stage

Survival varies with each type or subtype of tumour and the stage of uterine cancer. The grade of the cancer can also affect survival for uterine cancer.

Generally, the earlier uterine cancer is diagnosed and treated, the better the outcome. Uterine cancer is usually diagnosed early and can be completely removed by surgery.

There are no specific Canadian statistics available for the different stages and types of uterine cancer. The information for endometrial carcinoma and carcinosarcoma comes from the National Cancer Institute’s database.

Endometrial carcinoma survival
Stage5-year observed survival

0

90%

IA

88%

IB

75%

II

69%

IIIA

58%

IIIB

50%

IIIC

47%

IVA

17%

IVB

15%

Carcinosarcoma survival
Stage5-year relative survival

I

70%

II

45%

III

30%

IV

15%

The following information for uterine sarcoma comes from the National Cancer Institute’s SEER (Surveillance, Epidemiology and End Results) program. SEER uses these summary stages for uterine sarcoma survival statistics:

  • Localized corresponds to stage I.
  • Regional includes stages II and III.
  • Distant includes stages IVA and IVB.

Uterine leiomyosarcoma survival
Stage5-year relative survival

localized

63%

regional

36%

distant

14%

Endometrial stromal sarcoma survival
Stage5-year relative survival

localized

99%

regional

94%

distant

69%

Undifferentiated sarcoma survival
Stage5-year relative survival

localized

70%

regional

43%

distant

23%

Questions about survival

Talk to your doctor about prognosis. Prognosis depends on many factors, including:

  • your health history
  • the type of cancer
  • the stage
  • characteristics of the cancer
  • treatments chosen
  • your response to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.

Stories

Donna Blundon It is funny how one of the darkest times in your life can be one of the best times in your life, and it was all because of Daffodil Place.

Read Donna's story

Establishing a national caregivers strategy

Illustration of caregivers

The Canadian Cancer Society is actively lobbying the federal government to establish a national caregivers strategy to ensure there is more financial support for this important group of people.

Learn more